Haemonetics (HAE) Raw Materials (2011)
Haemonetics' quarterly Raw Materials came in at $35.3 million in Q4 2011, up 16.35% quarter-over-quarter from $30.4 million in Q3 2011.
Haemonetics has reported Raw Materials for 1 years, with the latest figure at $35.3 million in Q4 2011.
- For the quarter ending Q4 2011, Raw Materials changed N/A year-over-year to $35.3 million; the trailing twelve-month figure through Oct 2011 stood at $35.3 million (changed N/A YoY), and the FY2011 full-year result was $26.4 million, changed N/A from the prior year.
- Raw Materials for Q4 2011 stood at $35.3 million, up from $30.4 million in the prior quarter.
- The five-year high for Raw Materials was $35.3 million in Q4 2011, with the low at $26.4 million in Q2 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Haemonetics | 3.18 Bn | 2.93 Bn | 198.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 1, 2011 | 35.33 Mn |
| Jul 2, 2011 | 30.37 Mn |
| Apr 2, 2011 | 26.40 Mn |